Distribution of Improvements in Psoriasis Area and Severity Index from the Phase 2 Trial of Risankizumab in Moderate-to-Severe Plaque Psoriasis
Strober B, Papp K, Flack M, Gu Y, Thompson E, Valdecantos W. Distribution of Improvements in Psoriasis Area and Severity Index from the Phase 2 Trial of Risankizumab in Moderate-to-Severe Plaque Psoriasis. SKIN The Journal Of Cutaneous Medicine 2017, 1: s10. DOI: 10.25251/skin.1.supp.9.Peer-Reviewed Original Research